The Belt and Road: Cooperation, Harmony and Win-Win
products

Fine Chemical

  • Octreotide Acetate CAS:79517-01-4

    Octreotide Acetate CAS:79517-01-4

    Octreotide acetate is a synthetic analog of the natural hormone somatostatin, primarily used in the treatment of acromegaly, carcinoid tumors, and vasoactive intestinal peptide-secreting tumors. It works by inhibiting the release of certain hormones and neurotransmitters, thereby helping to reduce symptoms associated with these conditions. Octreotide acetate is available in injectable and long-acting release formulations, providing flexibility in the management of various disorders.

  • Somatostatin CAS:51110-01-1

    Somatostatin CAS:51110-01-1

    Somatostatin is a naturally occurring hormone that inhibits the release of various other hormones in the body. It plays a crucial role in regulating the endocrine system and is involved in the control of growth hormone, insulin, glucagon, and other gastrointestinal hormones.

  • Linaclotide CAS:851199-59-2

    Linaclotide CAS:851199-59-2

    Linaclotide is a guanylate cyclase-C agonist indicated for the treatment of chronic constipation and irritable bowel syndrome with constipation in adults. It works locally in the gastrointestinal tract to increase fluid secretion and accelerate intestinal transit, alleviating symptoms associated with these conditions.

  • Levosimendan CAS:141505-33-1

    Levosimendan CAS:141505-33-1

    Levosimendan is a calcium sensitizer and potassium channel opener used for the management of acute decompensated heart failure. This medication has inotropic and vasodilatory effects, improving cardiac function and relieving symptoms of heart failure.

  • Liraglutide CAS:204656-20-2

    Liraglutide CAS:204656-20-2

    Liraglutide is a medication used to treat type 2 diabetes and obesity. It belongs to the class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which work by increasing insulin production and decreasing the amount of sugar produced by the liver. Liraglutide is available in injectable form and is typically administered once daily. The medication has been shown to help lower blood sugar levels and promote weight loss in people with type 2 diabetes and obesity.

  • Octreotide Acetate CAS:83150-76-9

    Octreotide Acetate CAS:83150-76-9

    Octreotide acetate is a synthetic octapeptide analog of the natural hormone somatostatin. It acts as a potent inhibitor of various hormones and neuropeptides, and it is used in the management of conditions such as acromegaly, carcinoid syndrome, and certain types of tumors.

  • Semaglutide CAS:910463-68-2

    Semaglutide CAS:910463-68-2

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the management of type 2 diabetes and obesity. It works by regulating blood sugar levels, promoting weight loss, and reducing cardiovascular risk.

  • Icatibant Acetate CAS:138614-30-9

    Icatibant Acetate CAS:138614-30-9

    Icatibant acetate is a medication used for the treatment of hereditary angioedema (HAE), a rare genetic condition characterized by sudden and severe swelling of the skin, mucous membranes, and other body tissues. It is a selective bradykinin B2 receptor antagonist that works by blocking the effects of bradykinin, a key mediator of the swelling associated with HAE. Icatibant acetate is administered via subcutaneous injection and is designed to rapidly relieve symptoms of acute HAE attacks.

  • Ganirelix Acetate CAS:123246-29-7

    Ganirelix Acetate CAS:123246-29-7

    Ganirelix acetate is a medication used in assisted reproductive technology to prevent premature ovulation in women undergoing controlled ovarian hyperstimulation. By suppressing the release of luteinizing hormone, ganirelix acetate helps prevent early ovulation and supports optimal timing for egg retrieval during in vitro fertilization (IVF) procedures. It is administered through subcutaneous injections and plays a crucial role in the successful management of infertility treatments.

  • Linaclotide CAS:851199-59-2

    Linaclotide CAS:851199-59-2

    Linaclotide is a therapeutic agent used for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. As a guanylate cyclase-C agonist, linaclotide works locally in the gastrointestinal tract to increase fluid secretion and accelerate intestinal transit, thereby alleviating symptoms such as constipation and abdominal discomfort.

  • Ziconotide Acetate CAS:107452-89-1

    Ziconotide Acetate CAS:107452-89-1

    Ziconotide acetate is a synthetic version of the peptide compound derived from the venom of the Conus magus snail. It is used as an analgesic medication for the management of severe chronic pain in patients who are intolerant to or have not responded to other therapies. Ziconotide acetate is administered through intrathecal infusion, providing targeted relief for individuals experiencing refractory pain conditions.

  • Degarelix CAS:214766-78-6

    Degarelix CAS:214766-78-6

    Degarelix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of advanced prostate cancer. It works by rapidly suppressing the production of testosterone, a hormone that fuels the growth of prostate tumors.